Quest Diagnostics Incorporated Common Stock

Afficher le graphique complet Full chart

Financials

Total de l'actif 14.03 B13.61 B12.84 B14.02 B16.15 B16.23 B Total du passif 7.13 B7.05 B6.83 B7.6 B9.26 B8.94 B Total des capitaux propres 6.81 B6.48 B5.93 B6.34 B6.81 B7.21 B Total du passif et des capitaux propres 14.03 B13.61 B12.84 B14.02 B16.15 B16.23 B Dette totale 4.01 B4.01 B3.98 B4.41 B5.62 B5.17 B Dette nette 4.01 B4.01 B3.98 B4.41 B5.62 B5.17 B

Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe. As of 2020, the company had approximately 48,000 employees, and it generated more than $7.7 billion in revenue in 2019. The company offers access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders, COVID-19, and employment and court-ordered drug testing.

DGX

Financials

Quest Diagnostics Incorporated Common Stock

Nouvelles

Quest Diagnostics (DGX) Upgraded to Buy: Here's What You Should Know

The latest Oura and Fitbit wearables are smarter and sleeker than ever — but do they keep you healthy?

Here's Why Quest Diagnostics (DGX) is a Strong Value Stock

Are Medical Stocks Lagging Quest Diagnostics (DGX) This Year?

Quest Diagnostics Stock: Analyst Estimates & Ratings

Les actionnaires de Quest Diagnostics élisent les administrateurs lors de l’assemblée annuelle

Why Is Quest Diagnostics (DGX) Down 5% Since Last Earnings Report?

Reasons to Add Align Technology Stock to Your Portfolio Now

Quest Diagnostics déclare un dividende trimestriel de 0,86$

Is This the Right Time to Hold DGX Stock in Your Portfolio?

Digi Power X publiera ses résultats du T1 2026 jeudi

Digi Power X porte son programme d’offre d’actions à 175 millions $